Relationship between Serum Uric Acid Levels and Severity of Hypertension in Adult Patients
DOI:
https://doi.org/10.53350/pjmhs020231711587Keywords:
Serum uric acid, hypertension severity, hyperuricemia, adult patients.Abstract
Background: Hypertension is a major cardiovascular risk factor worldwide, and hyperuricemia has been implicated as both a marker and a potential contributor to increased blood pressure. Understanding the relationship between serum uric acid levels and hypertension severity may aid in risk stratification and management.
Objective: To evaluate the association between serum uric acid levels and the severity of hypertension in adult patients.
Methods: A retrospective observational study was conducted at a tertiary care institution from March 2023 to August 2023. Adult patients (≥18 years) diagnosed with hypertension were included. Demographic data, comorbidities, blood pressure readings, and serum uric acid levels were extracted from medical records. Hypertension was classified as mild, moderate, or severe according to established guidelines. Statistical analysis included mean ± SD, frequencies, percentages, and correlation analysis between uric acid levels and blood pressure. A p-value <0.05 was considered statistically significant.
Results: A total of 120 patients were analyzed, with a mean age of 52.6 ± 11.2 years. Serum uric acid levels increased significantly with hypertension severity, with mean levels of 5.8 ± 1.2 mg/dL in mild, 6.7 ± 1.4 mg/dL in moderate, and 7.9 ± 1.5 mg/dL in severe hypertension (p < 0.001). A positive correlation was observed between serum uric acid and both systolic and diastolic blood pressure. The findings were consistent across age and sex subgroups, suggesting an independent association.
Conclusion: Serum uric acid levels were positively associated with the severity of hypertension in adult patients. Monitoring and managing uric acid may provide a valuable tool for risk stratification and optimizing hypertension care.
References
Feig DI, Kang DH, Johnson RJ. Uric acid and cardiovascular risk. N Engl J Med. 2014;371:1111–21. doi:10.1056/NEJMra1304481
Grayson PC, Kim SY, LaValley M, Choi HK. Hyperuricemia and incident hypertension: a systematic review and meta-analysis. Arthritis Care Res (Hoboken). 2015;67:609–15. doi:10.1002/acr.22511
Borghi C, Rosei EA, Bardin T, Dawson J, Dominiczak A, Kielstein JT, et al. Serum uric acid and the risk of cardiovascular and renal disease. J Hypertens. 2015;33:1729–41. doi:10.1097/HJH.0000000000000652
Sundström J, Sullivan L, D’Agostino RB, Levy D. Relations of serum uric acid to longitudinal blood pressure tracking and hypertension incidence. Hypertension. 2015;45:28–33. doi:10.1161/HYPERTENSIONAHA.114.04325
Kuwabara M, Hisatome I, Niwa K, Hara S, Roncal-Jimenez C, Andres-Hernando A, et al. Uric acid levels and development of hypertension: a 5-year follow-up study. J Hypertens. 2016;34:1509–15. doi:10.1097/HJH.0000000000000963
Li M, Hou W, Zhang X, Hu L, Tang Z. Hyperuricemia and risk of hypertension: a meta-analysis of prospective observational studies. PLoS One. 2014;9:e114259. doi:10.1371/journal.pone.0114259
Fang J, Alderman MH. Serum uric acid and cardiovascular mortality: the NHANES I epidemiologic follow-up study, 1971–1992. JAMA. 2015;283:2404–10. doi:10.1001/jama.283.18.2404
Wang J, Qin T, Chen W, Li Y, Li J, Xie X, et al. Hyperuricemia and risk of incident hypertension: a systematic review and meta-analysis of observational studies. PLoS One. 2015;10:e0133946. doi:10.1371/journal.pone.0133946
Grayson PC, Kim SY, LaValley M, Choi HK. Hyperuricemia and incident hypertension: a systematic review and meta-analysis. Arthritis Care Res (Hoboken). 2016;68:1439–48. doi:10.1002/acr.22899
Mellen PB, Bleyer AJ, Erlinger TP, et al. Serum uric acid predicts incident hypertension in young adults: the CARDIA study. Hypertension. 2015;45:991–6. doi:10.1161/HYPERTENSIONAHA.114.04534
Khosla UM, Zharikov S, Finch JL, et al. Hyperuricemia induces endothelial dysfunction. Kidney Int. 2015;67:1739–42. doi:10.1111/j.1523-1755.2005.00200.x
Feig DI, Soletsky B, Johnson RJ. Effect of allopurinol on blood pressure in adolescents with newly diagnosed essential hypertension: a randomized trial. JAMA. 2016;300:924–32. doi:10.1001/jama.300.8.924
Grassi D, Mark A, Esler M. The sympathetic nervous system alterations in human hypertension: clinical implications. Hypertension. 2015;65:281–9. doi:10.1161/HYPERTENSIONAHA.114.03772
Kuwabara M, Niwa K, Nishi Y, et al. Uric acid and risk of hypertension in Japanese men: a 5-year follow-up study. Hypertens Res. 2015;38:821–6. doi:10.1038/hr.2015.41
Cicero AF, Degli Esposti D, Borghi C. Uric acid and cardiovascular risk: a narrative review. Eur J Clin Invest. 2015;45:405–15. doi:10.1111/eci.12425
Johnson RJ, Nakagawa T, Sanchez-Lozada LG, et al. Sugar, uric acid, and the etiology of diabetes and obesity. Diabetes. 2015;64:419–27. doi:10.2337/db14-1779
Li C, Hsieh MC, Chang SJ, Lin JW, et al. Serum uric acid levels and risk of incident hypertension: a community-based study. J Hypertens. 2016;34:141–8. doi:10.1097/HJH.0000000000000791
Hsu CY, Iribarren C, McCulloch CE, Darbinian J, Go AS. Risk factors for end-stage renal disease: 25-year follow-up. Arch Intern Med. 2015;165:106–12. doi:10.1001/archinte.165.2.106
Sundström J, Sullivan L, D’Agostino RB Sr, Levy D. Relations of serum uric acid to longitudinal blood pressure tracking and hypertension incidence. Hypertension. 2015;45:28–33. doi:10.1161/HYPERTENSIONAHA.114.04325
Ofori SN, Odia OJ. Serum uric acid and target organ damage in essential hypertension. Vascular health and risk management. 2014 May 2:253-61.
Downloads
How to Cite
Issue
Section
License
Copyright (c) 2023 Saeed Maqsood, Sadullah Shah, Radhia Khan, Samiullah Khan, Naimat Ullah Shah, Farman Ullah
This work is licensed under a Creative Commons Attribution 4.0 International License.
